Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC)

BJU International

Volumn 107, Issue 6, 2011, Pages 912-918

  Colombo, Renzo ^a   Salonia, Andrea ^a   Leib, Zvi ^c   Pavone Macaluso, Michele ^b   Engelstein, Dov ^c  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c Rabin Medical Center Beilinson Campus ^*  (Israel)

Author keywords

Bladder cancer; Chemotherapy; Local hyperthermia; Mitomycin C; Non muscle invasive bladder cancer (NMIBC); Treatment

Indexed keywords

MITOMYCIN C;

ADJUVANT THERAPY; AGED; ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HYPERTHERMIC THERAPY; MAJOR CLINICAL STUDY; MALE; NONMUSCLE INVASIVE BLADDER CANCER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURVIVAL RATE; SURVIVAL TIME;

ADMINISTRATION, INTRAVESICAL; AGED; ANTIBIOTICS, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM INVASIVENESS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 79952613351     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09654.x     Document Type: Article

References (24)

1. Pawinski A, Sylvester R, Kurth KH et al. A combined analysis of European Organisation for Cancer Research and Treatment of Cancer and Medical Research Cancer clinical trials for the prophylactic treatment of stage Ta-T1 bladder cancer. J Urol 1996; 156: 1934-41 (Pubitemid 26378022)
2. Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J, European Association of Urology (EAU). EAU guidelines on non-muscleinvasive urothelial carcinoma of the bladder. Eur Urol 2008; 54: 303-14
3. Lerner SP, Au JL. Risk-adapted use of intravesical chemotherapy. BJU Int 2008; 102: 1247-53
4. Lamm DL, Riggs DR, Traynelis CL, Nseyo UO. Apparent failure of current intravesical chemotherapy prophylaxis to influence the long-term course of superficial transitional cell carcinoma of the bladder. J Urol 1995; 153: 1144-50
5. Malmstrom PU. Intravesical therapy of superficial bladder cancer. Crit Rev Oncol Hematol 2003; 47: 109-26
6. Thrasher JB, Crawford ED. Complications of intravesical chemotherapy. Urol Clin North Am 1992; 19: 529-39
7. Colombo R, Lev A, Da Pozzo LF, Freschi M, Gallus G, Rigatti P. A new approach using local combined microwave hyperthermia and chemotherapy in superficial transitional bladder carcinoma treatment. J Urol 1995; 153: 959-63
8. Gofrit ON, Shapiro A, Pode D et al. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer. Urology 2004; 63: 466-71
9. van der Heijden AG, Kiemeney LA, Gofrit ON et al. Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder. Eur Urol 2004; 46: 65-72 (Pubitemid 38748512)
10. Moskovitz B, Meyer G, Kravtzov A et al. Thermo-chemotherapy for intermediate or high-risk recurrent superficial bladder cancer patients. Ann Oncol 2005; 16: 585-9 (Pubitemid 40613324)
11. Colombo R, Da Pozzo LF, Salonia A et al. Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol 2003; 21: 4270-6 (Pubitemid 46621801)
12. Cookson MS, Herr HW, Zhang ZF, Soloway S, Sogani PC, Fair WR. The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol 1997; 158: 62-7 (Pubitemid 27251595)
13. Gårdmark T, Jahnson S, Wahlquist R, Wijkström H, Malmström PU. Analysis of progression and survival after 10 years of a randomized prospective study comparing mitomycin-C and bacillus Calmette-Guérin in patients with highrisk bladder cancer. BJU Int 2007; 99: 817-20
14. Sylvester RJ, van der Meijden AP, Oosterlinck W et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006; 49: 466-77
15. Sylvester RJ, Oosterlinck W, van der Meijden AP. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol 2004; 171: 2186-90 (Pubitemid 38625431)
16. Gudjónsson S, Adell L, Merdasa F et al. Should all patients with non-muscleinvasive bladder cancer receive early intravesical chemotherapy after transurethral resection? The results of a prospective randomised multicentre study. Eur Urol 2009; 55: 773-80
17. Böhle A, Leyh H, Frei C et al. Single postoperative instillation of gemcitabine in patients with non-muscle-invasive transitional cell carcinoma of the bladder: a randomised, double-blind, placebocontrolled phase III multicentre study. Eur Urol 2009; 56: 495-503
18. Witjes JA, Hendricksen K. Intravesical pharmacotherapy for non-muscleinvasive bladder cancer: a critical analysis of currently available drugs, treatment schedules, and long-term results. Eur Urol 2008; 53: 45-52 (Pubitemid 350167566)
19. Nilsson S, Ragnhammar P, Glimelius B, Nygren P, SBU-group. Swedish Council of Technology Assessment in Health Care. A systematic overview of chemotherapy effects in urothelial bladder cancer. Acta Oncol 2001; 40: 371-90 (Pubitemid 32588129)
20. Lamm DL. Long-term results of intravesical chemotherapy for superficial bladder cancer. Urol Clin North Am 1992; 19: 573-80
21. Herman TS, Teicher BA, Jochelson M, Clark J, Svensson G, Coleman CN. Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies. Int J Hyperthermia 1988; 4: 143-58 (Pubitemid 18065157)
22. van der Heijden AG, Jansen CF, Verhaegh G, O'donnell MA, Schalken JA, Witjes JA. The effect of hyperthermia on mitomycin-C induced cytotoxicity in four human bladder cancer cell lines. Eur Urol 2004; 46: 670-4 (Pubitemid 39345746)
23. van der Heijden AG, Verhaegh G, Jansen CF, Schalken JA, Witjes JA. Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro study. J Urol 2005; 173: 1375-80 (Pubitemid 40380578)
24. van der Heijden AG, Hulsbergen-Van de Kaa CA, Witjes JA. The influence of thermo-chemotherapy on bladder tumours: an immunohistochemical analysis. World J Urol 2007; 25: 303-8